{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Abobotulinumtoxina+for+Injection&page=6", "query": { "intervention": "Abobotulinumtoxina for Injection", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 286, "total_pages": 29, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Abobotulinumtoxina+for+Injection&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Abobotulinumtoxina+for+Injection&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-11T10:38:14.028Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04240535", "title": "Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Aging" ], "interventions": [ { "name": "OnabotulinumtoxinA 50 UNT [Botox Cosmetic]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amir Moradi MD, MBA", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2020-01", "completion_date": "2020-07", "has_results": false, "last_update_posted_date": "2020-01-27", "last_synced_at": "2026-10-11T10:38:14.028Z", "location_count": 1, "location_summary": "Vista, California", "locations": [ { "city": "Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04240535" }, { "nct_id": "NCT00971620", "title": "Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cutaneous Leiomyomas", "Hereditary Leiomyomatosis and Renal Cell Cancer" ], "interventions": [ { "name": "Botulinum toxin type A", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2008-11-17", "completion_date": "2016-10-12", "has_results": true, "last_update_posted_date": "2017-04-07", "last_synced_at": "2026-10-11T10:38:14.028Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00971620" }, { "nct_id": "NCT00945295", "title": "Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Upper Limb Spasticity" ], "interventions": [ { "name": "Botulinum toxin type A, BoNT-A", "type": "DRUG" }, { "name": "Rehabilitation Therapy", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "JoAnn Harnar", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 31, "start_date": "2009-01", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2013-11-01", "last_synced_at": "2026-10-11T10:38:14.028Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT00945295" }, { "nct_id": "NCT04763265", "title": "Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Frown Lines" ], "interventions": [ { "name": "Botulinum toxin A \"BoNT/A-DP\"", "type": "BIOLOGICAL" }, { "name": "Botulinum toxin A \"Botox Cosmetics\"", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Croma-Pharma GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 208, "start_date": "2020-06-24", "completion_date": "2021-02-01", "has_results": true, "last_update_posted_date": "2025-03-18", "last_synced_at": "2026-10-11T10:38:14.028Z", "location_count": 2, "location_summary": "Santa Monica, California • Coral Gables, Florida", "locations": [ { "city": "Santa Monica", "state": "California" }, { "city": "Coral Gables", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04763265" }, { "nct_id": "NCT02074163", "title": "ASIS for Botox in Chronic Migraine", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Chronic Migraine More than15 Days Per Month, and Lasting 4 Hours a Day or Longer." ], "interventions": [ { "name": "Gadolinium", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 6", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 12", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 18", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 24,", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 30", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 6", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 12", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 18", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 24", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 30", "type": "DRUG" }, { "name": "Adverse Reactions of Botox intramuscularly", "type": "DRUG" }, { "name": "Adverse Reactions of Botox subdermally", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ASIS Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2016-01", "completion_date": "2017-06", "has_results": false, "last_update_posted_date": "2015-06-24", "last_synced_at": "2026-10-11T10:38:14.028Z", "location_count": 1, "location_summary": "Westminster, California", "locations": [ { "city": "Westminster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02074163" }, { "nct_id": "NCT00479154", "title": "Botulinum Toxin to Treat Restless Legs Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Restless Legs Syndrome" ], "interventions": [ { "name": "Botulinum Toxin A", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 6, "start_date": "2007-05", "completion_date": "2008-04", "has_results": true, "last_update_posted_date": "2012-04-26", "last_synced_at": "2026-10-11T10:38:14.028Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00479154" }, { "nct_id": "NCT05892770", "title": "Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Spasmodic Dysphonia" ], "interventions": [ { "name": "Zinc gluconate supplement", "type": "DRUG" }, { "name": "Botulinum toxin type A", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 32, "start_date": "2023-08-01", "completion_date": "2025-03-01", "has_results": true, "last_update_posted_date": "2026-07-27", "last_synced_at": "2026-10-11T10:38:14.028Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05892770" }, { "nct_id": "NCT02074293", "title": "ASIS for Botox in Cervical Dystonia", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cervical Dystonia Adults ,", "Abnormal Head Position and Neck Pain for These 7 Muscle Groups: Splenius,Scalene,Sterno-cleido-mastoid,Levator Scapulae,Semispinalis,Trapezius,and Longissimus." ], "interventions": [ { "name": "Gadolinium", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 6", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 12", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 18", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 24", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 30", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 6", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 12", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 18", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 24", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 30", "type": "DRUG" }, { "name": "Adverse Reactions of Botox intramuscularly", "type": "DRUG" }, { "name": "Adverse Reactions of Botox subdermally", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "li nguyen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2016-01", "completion_date": "2017-06", "has_results": false, "last_update_posted_date": "2015-06-24", "last_synced_at": "2026-10-11T10:38:14.028Z", "location_count": 1, "location_summary": "Westminster, California", "locations": [ { "city": "Westminster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02074293" }, { "nct_id": "NCT02334436", "title": "A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glabellar Frown Lines" ], "interventions": [ { "name": "Botulinum toxin, Type A", "type": "BIOLOGICAL" }, { "name": "0.9% sterile, unpreserved saline", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Evolus, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 324, "start_date": "2015-01", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2019-03-27", "last_synced_at": "2026-10-11T10:38:14.028Z", "location_count": 1, "location_summary": "Beverly Hills, California", "locations": [ { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02334436" }, { "nct_id": "NCT02557971", "title": "Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Urinary Bladder, Overactive" ], "interventions": [ { "name": "onabotulinumtoxinA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 315, "start_date": "2015-08", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2016-09-02", "last_synced_at": "2026-10-11T10:38:14.028Z", "location_count": 7, "location_summary": "Davis, California • Irvine, California • Charlotte, North Carolina + 4 more", "locations": [ { "city": "Davis", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Greensboro", "state": "North Carolina" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02557971" } ] }